DHAI (DIH Holding US) Operating Margin %: -25.36% (As of Mar. 2025)


What is DIH Holding US Operating Margin %?

DIH Holding US DHAI Operating Margin % is -25.36% as of Mar. 2025.

Operating Margin % is calculated as Operating Income divided by its Revenue. DIH Holding US's Operating Income for the three months ended in Mar. 2025 was $-3.21 Mil. DIH Holding US's Revenue for the three months ended in Mar. 2025 was $12.65 Mil. Therefore, DIH Holding US's Operating Margin % for the quarter that ended in Mar. 2025 was -25.36%.

The historical rank and industry rank for DIH Holding US's Operating Margin % or its related term are showing as below:


DHAI's Operating Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.465
* Ranked among companies with meaningful Operating Margin % only.

DIH Holding US's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

DIH Holding US's Operating Income for the three months ended in Mar. 2025 was $-3.21 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was $-5.72 Mil.


DIH Holding US  (OTCPK:DHAI) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


DIH Holding US Operating Margin % Related Terms


DIH Holding US Operating Margin % Historical Data

* Premium members only.

The historical data trend for DIH Holding US's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US Operating Margin % Chart

DIH Holding US Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Operating Margin %
-21.33 -0.40 -4.05 -7.74

DIH Holding US Quarterly Data
Mar22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -10.22 10.40 -18.19 -25.36

DHAI vs ABT, SYK, MDT: Operating Margin % Comparison

For the Medical Devices subindustry, DIH Holding US's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DIH Holding US Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DIH Holding US's Operating Margin % distribution charts can be found below:

* The bar in red indicates where DIH Holding US's Operating Margin % falls into.



DIH Holding US Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

DIH Holding US's Operating Margin % for the fiscal year that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (A: Mar. 2025 ) / Revenue (A: Mar. 2025 )
=-4.864 / 62.864
=-7.74 %

DIH Holding US's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=-3.207 / 12.648
=-25.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -25.36% mean?
DIH Holding US (DHAI) has a Operating Margin % of -25.36% as of Mar. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's Operating Margin % too high?
DIH Holding US's current Operating Margin % is -25.36%.
How does DIH Holding US's Operating Margin % compare to ABT and SYK?
DIH Holding US's Operating Margin % of -25.36% can be compared against companies in the Medical Devices & Instruments industry. The industry median Operating Margin % is 3.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on DIH Holding US and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DIH Holding US's current Operating Margin % is -25.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current Operating Margin % of -25.36%. The current Operating Margin % is -25.36%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For DIH Holding US (DHAI), the current Operating Margin % is -25.36% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DIH Holding US Business Description

Address 77 Accord Park Drive, Suite D-1, Norwell, MA, USA, 02061
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.